SRP-4053

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRP-4053, covering 2020-10-19 to 2020-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of SRP-4053 in DMD Patients [Phase 1, Phase 2]